跳至主要内容
临床试验/NCT00264225
NCT00264225已完成3 期

A Randomized, Double-Blind, Comparative Parallel Group Study of Analgesic Effectiveness and Safety of Three Different Doses of Lamaline® New Formulation vs Dafalgan® Codeine, After 10 Days Administration in Subjects With Painful Gonarthrosis.

Solvay Pharmaceuticals171 个研究点 分布在 1 个国家开始时间: 2005年12月1日最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
已完成
试验地点
171

研究概览

简要总结

This study aims to assess the analgesic effectiveness and safety of three different doses of a new formulation of Lamaline® versus Dafalgan® Codeine after 10 days administration in subjects with painful gonarthrosis

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
40 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •History of knee (unilateral or bilateral) osteoarthritis for at least 6 months
  • •Pain intensity assessed by Visual Analogue Scale ≥ 40 mm
  • •Partial functional disability assessed by Lequesne index ≥4 and < than 12

排除标准

  • •Patient unable to interrupt his/her NSAIDs to participate in the clinical study

研究者

申办方类型
Industry

研究点 (171)

Loading locations...

相似试验